Tìm kiếm
CorMedix Inc
CRMDThêm vào danh sách theo dõi
7.770USD
+0.080+1.04%
Đóng cửa 09-24 16:00（ET）
609.56MVốn hóa
3.19P/E TTM
Giới thiệu về CorMedix Inc Công ty
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.
CorMedix Inc Hồ sơ
Mã chứng khoánCRMD
Tên công tyCorMedix Inc
Ngày IPOMar 25, 2010
Giám đốc điều hànhTodisco (Joseph)
Số lượng nhân viên64
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhMar 25
Địa chỉ300 Connell Drive
Thành phốBERKELEY HEIGHTS
Sàn giao dịch chứng khoánNASDAQ OMX - NASDAQ BASIC
Quốc giaUnited States of America
Mã bưu điện07922
Điện thoại19085179500
Trang webhttps://cormedix.com/
Mã chứng khoánCRMD
Ngày IPOMar 25, 2010
Giám đốc điều hànhTodisco (Joseph)
Lãnh đạo công ty của CorMedix Inc
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
401.08K
-41.48%
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
401.08K
-41.48%
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
401.08K
-41.48%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
124.31K
-6.78%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
124.31K
-6.78%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
124.31K
-6.78%
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
87.38K
+55.97%
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
401.08K
-41.48%
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
401.08K
-41.48%
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
401.08K
-41.48%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Câu hỏi thường gặp
Ai là năm cổ đông lớn nhất của CorMedix Inc?
Năm cổ đông hàng đầu của CorMedix Inc là: Mr. Joseph (Joe) Todisco
Có bao nhiêu tổ chức nắm giữ cổ phiếu của CorMedix Inc (CRMD)?
Tính đến ngày 2026Q1, có 390 tổ chức nắm giữ cổ phiếu của CorMedix Inc, với tổng giá trị thị trường khoảng 43.28M, chiếm 55.17% tổng số cổ phiếu. So với ngày 2025Q4, tỷ lệ cổ phần của các tổ chức đã tăng thêm -18630389.00.